The Saudi Ministry of Investment and Janssen, a subsidiary of Johnson & Johnson, signed a Memorandum of Understanding to establish a partnership to develop strategic initiatives to enhance healthcare and life sciences capabilities in the Kingdom.
The memorandum will promote societal, health, and economic development, thus playing a role in achieving the Kingdom’s Vision 2030.
In an interview with Al Arabiya, Saudi Investment Minister Khalid Al-Falih said that this important agreement is comprehensive and is the fourth in a series of agreements signed by Johnson & Johnson under the auspices of the Ministry of Investment and the Ministry of Industry with several parties.
Johnson signed an agreement with the Al-Dawaa company to manufacture two types of advanced drugs and a research memorandum with King Abdullah University of Science and Technology related to medical research in one of the diseases prevalent in the Kingdom.
The agreement focuses on innovation, new product development, clinical examinations and studies, access to information and the governance of its dissemination.
The Kingdom helps organize the regulatory and legislative environment in partnership with the leading company to achieve one of the Kingdom’s Vision 2030 goals.
The company aims to provide medical products to people through the development of the health sector with a rare global partnership between various sectors representing government and local & global private sector.